Development of healthcare quality indicators for rheumatoid arthritis in Europe: the eumusc.net project

Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial

Lars Klareskog, Désirée van der Heijde, J Jäger et al. · The Lancet · 2004 · 1.8K citations

Rheumatoid Disorder, Rheumatology, Therapeutic Effect +8

Inequities in access to biologic and synthetic DMARDs across 46 European countries

Polina Putrik, Sofía Ramiro, Tore K Kvien et al. · Annals of the Rheumatic Diseases · 2013 · 340 citations · Full text

Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial

Ronald van Vollenhoven, Sofia Ernestam, P. Geborek et al. · The Lancet · 2009 · 316 citations

Inflammation, Rheumatology, Rheumatoid Disorder +12

Incorporating the patient perspective into outcome assessment in rheumatoid arthritis--progress at OMERACT 7.

John Kirwan, Sarah Hewlett, Turid Heiberg et al. · PubMed · 2005 · 223 citations

Patient Perspective Workshop, Inflammatory Arthritis, Rheumatoid Disorder +16

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST–RA database

Tuulikki Sokka, Hannu Kautiainen, Theodore Pincus et al. · Annals of the Rheumatic Diseases · 2009 · 204 citations · Full text